Spravato has been approved since 2019 for TRD, with its label extended the following year as a rescue therapy for adults with major depressive disorder (MDD) who were at risk of self-harm or suicide.

Spravato can help patients experience improvements in depressive symptoms as early as 24 hours and at 28 days—without the need for daily oral antidepressants. The nasal spray works by targeting ...

Spravato works on the glutamate NMDA receptor in the brain and is closely related to ketamine – an anaesthetic that is also misused as a recreational drug, as it can have hallucinogenic effects.

After that, patients can work with their healthcare provider to decide if they should continue taking Spravato once a week or every two weeks to maintain remission. Malina said some patients feel ...

So what is going to work? How can you exploit an existing infrastructure? That's really been our focus. And, again, Spravato is a very good place to start. I think we can expand from there ...

By learning about possible Spravato interactions, you can work with your doctor to ensure Spravato will be safe and effective for you. For additional information about Spravato, including details ...

Living Local 15 host Jessica Williams is joined by Sean Goddard, a Psychiatric Nurse Practitioner and Owner of Viking Psychiatry, to speak about the recent approval for Spravato as a monotherapy ...

Stella Mental Health Westmont is a top depression and anxiety clinic near Chicago that offers comprehensive mental health treatments like Spravato (esketamine) therapy, ketamine infusion ...

Stella Mental Health in Westmont specializes in medication management, Spravato (esketamine) nasal spray, transcranial magnetic stimulation (TMS), ketamine infusion therapy, stellate ganglion ...